The Role of the Dopamine β-hydroxylase Functional Polymorphism in Patients with Early-Onset Parkinson’s Disease in the Turkish Population
Journal Title: Turkish Journal of Neurology - Year 2021, Vol 27, Issue 1
Abstract
Objective: A functional single nucleotide polymorphism, rs1611115, in the dopamine β-hydroxylase (DBH) gene, is reported to regulate plasma enzyme activity levels. Here, we report the first evaluation of this association in patients with early-onset Parkinson’s disease (EOPD) and healthy controls in the Turkish population. Materials and Methods: We evaluated the DBH rs1611115 polymorphism in 114 (64 male and 50 female) Turkish patients with EOPD and 58 sex- and agematched healthy controls from the Turkish population. A total of 27.2% (n=31) of our patients who had any variation including pathogenic or non-pathogenic missense, non-sense and/or intronic variation with unknown significance in EOPD genes were grouped as “variation-positive EOPD”. A total of 50.8% (n=58) of our patients were grouped as “variation and family history-negative EOPD” and the possible contribution of the DBH rs1611115 polymorphism to EOPD pathogenesis was evaluated in this group. Results: There was no significant difference in the genotypic and allelic frequencies of DBH rs1611115 between patients with EOPD and controls. To our knowledge, this is the first evaluation of the DBH rs1611115 polymorphism in patients with EOPD and ethnically matched controls in the Turkish population. Conclusion: Some previous studies have reported conflicting association results between DBH rs1611115 polymorphism and PD pathogenesis in different ethnic groups. Therefore, further studies are needed to evaluate dopamine metabolism-related genetic variants and to determine their possible roles in EOPD susceptibility in the Turkish population.
Authors and Affiliations
Sevda Erer, Işıl Ezgi Eryılmaz, Dilara Kamer Çolak, Ünal Egeli, Gülşah Çeçener, Berrin Tunca, Ece Karakuş, Beril Çolakoğlu, Ayşe Bora Tokçaer, Esen Saka, Meltem Demirkıran, Cenk Akbostancı, Mehmet Zarifoğlu, Okan Doğu, Hakan Kaleağası, Gülay Kenangil, Raif Çakmur, Bülent Elibol
Experience of Intravenous Thrombolytic Treatment in Sanliurfa: A Prospective Study
Objective: Stroke ranks second among the diseases that cause death and third among the causes of disability in Turkey. An average of 1.9 million neurons die every minute due to acute ischemic stroke and therefore ‘time i...
Modelling Non-motor Symptoms of Parkinson’s Disease: AAV Mediated Overexpression of Alpha-synuclein in Rat Hippocampus and Basal Ganglia
Objective: Our aim was to investigate the relation between unilateral hippocampal and/or nigral alpha-synucleinopathy and cognitive dysfunction, anxiety and anhedonia. Materials and Methods: Female Sprague-Dawley rats w...
Post Blood Transfusion Reversible Cerebral Vasoconstriction with Posterior Leukoencephalopathy Syndrome
Reversible Cerebral Vasoconstriction syndrome is an uncommon and often under-diagnosed neurologic disorder. It is characterized by thunderclap headache with or without focal neurologic deficits and seizures. Common provo...
The Comparison of the Effects of Two Botulinum Toxin A Injection Methods, Follow the Pain and Fixed-site Fixed-dose, on Improving the Quality of Life and Headaches in Patients with Chronic Migraine: A Preliminary Randomized Clinical Trial
Objective: Migraine headaches are one of the most common and debilitating diseases. Chronic migraine (CM) is a type of migraine that reduces quality of life and causes disability. Botulinum toxin A (BT-A) was approved in...
False-negative Diffusion-weighted Imaging in a Patient with Basilar Artery Syndrome Presenting with Isolated Vertigo
No summary